KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Current Taxes (2016 - 2025)

Historic Current Taxes for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $28.1 million.

  • West Pharmaceutical Services' Current Taxes fell 1079.37% to $28.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.1 million, marking a year-over-year decrease of 1079.37%. This contributed to the annual value of $28.1 million for FY2025, which is 1079.37% down from last year.
  • Latest data reveals that West Pharmaceutical Services reported Current Taxes of $28.1 million as of Q4 2025, which was down 1079.37% from $33.3 million recorded in Q3 2025.
  • West Pharmaceutical Services' Current Taxes' 5-year high stood at $59.0 million during Q1 2023, with a 5-year trough of $15.0 million in Q3 2023.
  • In the last 5 years, West Pharmaceutical Services' Current Taxes had a median value of $28.3 million in 2025 and averaged $29.2 million.
  • Per our database at Business Quant, West Pharmaceutical Services' Current Taxes skyrocketed by 25755.4% in 2021 and then crashed by 7152.54% in 2024.
  • West Pharmaceutical Services' Current Taxes (Quarter) stood at $26.3 million in 2021, then fell by 5.7% to $24.8 million in 2022, then tumbled by 33.06% to $16.6 million in 2023, then skyrocketed by 89.76% to $31.5 million in 2024, then fell by 10.79% to $28.1 million in 2025.
  • Its last three reported values are $28.1 million in Q4 2025, $33.3 million for Q3 2025, and $28.5 million during Q2 2025.